A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study

CompletedOBSERVATIONAL
Enrollment

98

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Actinic Keratosis
Interventions
DRUG

Lesion count

Lesion count in area treated by study drug in a prior study over a 12 month period No drug will be applied during this long-term follow up study. Drug was applied during the primary study.

Trial Locations (11)

3141

Dermatology Institute of Victoria, Melbourne

5006

Dematology on Ward, Adelaide

6008

St John of God Dermatology, Subiaco

14623

Dermatology Associates of Rochester, Rochester

30263

Medaphase Inc, Newnan

32073

Park Avenue Dermatology, Orange Park

37203

Dermatology Research Associates, Nashville

48038

Michigan Center for Research Corp, Clinton Twp

48202

Henry Ford Health Systems, Detroit

30078-3250

Gwinnett Clinical Research Centre, Snellville

97239-4501

Oregon Health and Science University, Portland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Peplin

INDUSTRY

NCT00952783 - A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study | Biotech Hunter | Biotech Hunter